This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Lincoln (LNC) Q3 Earnings Miss on Lower Annuities Profits
by Zacks Equity Research
Lincoln (LNC) returns $76 million in the form of common dividends to its shareholders in the third quarter.
Resuming the Bull Market: 3 Top Ranked Stocks Investors Can Buy Now
by Ethan Feller
Following yesterday's Fed meeting, the market is ready to rally
MetLife (MET) Q3 Earnings Miss Despite Rising Investment Returns
by Zacks Equity Research
MetLife (MET) exits the third quarter with cash and cash equivalents of $14.9 billion.
Aflac's (AFL) Q3 Earnings Beat on Lower Benefits and Claims
by Zacks Equity Research
Improving productivity, contributions from platforms like network, dental and vision and group life are likely to buoy Aflac's (AFL) U.S. operations.
Down -21.83% in 4 Weeks, Here's Why Trupanion (TRUP) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Trupanion (TRUP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Can AIG Q3 Earnings Beat on Strong General Insurance Growth?
by Zacks Equity Research
AIG's third-quarter results are expected to showcase strong North America operations and growing premium rates.
Trupanion (TRUP) Loses -26.63% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Trupanion (TRUP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Hartford Financial (HIG) Q3 Earnings Beat on Commercial Lines Unit
by Zacks Equity Research
Hartford Financial's (HIG) Q3 results reflect growing premiums in the Group Benefits business and improved net investment income, partly offset by higher expenses.
AMERISAFE (AMSF) Q3 Earnings Miss on Lower Premiums Earned
by Zacks Equity Research
AMERISAFE's (AMSF) board declares a special dividend of $3.50 per share to return excess capital to shareholders.
Trupanion (TRUP) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amerisafe (AMSF) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of -4.69% and 0.24%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Central Garden & Pet (CENT) Advances in 3 Months: Here's Why
by Zacks Equity Research
Central Garden & Pet (CENT) is taking proactive approaches to solidify its position in the competitive pet supplies, and lawn and garden products market in the United States.
Here's Why You Should Consider Investing in Trupanion (TRUP)
by Zacks Equity Research
Trupanion's (TRUP) heightened focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position poise it well for growth.
HCI Group's (HCI) TypTap Gets Regulatory Nod to Assume Policies
by Zacks Equity Research
Per the regulatory approval, HCI Group's (HCI) subsidiary TypTap will assume up to 25,000 policies from Florida's Citizens Property Insurance Corporation.
Here's Why Hold Strategy is Apt for eHealth (EHTH) Stock Now
by Zacks Equity Research
eHealth's (EHTH) transformation initiatives are lowering its costs and expanding margins.
Here's Why You Should Retain MarketAxess (MKTX) Stock for Now
by Zacks Equity Research
Higher commissions, new data contract revenue, growing international business and improved liquidity poise MarketAxess (MKTX) well for growth.
Manulife's (MFC) John Hancock Launches New Insurance Product
by Zacks Equity Research
Manulife's (MFC) John Hancock enhances its product portfolio by launching the Premier Benefit Indexed Universal Life product.
Allstate (ALL) Continues Auto Rate Hikes to Boost Profits
by Zacks Equity Research
Allstate (ALL) reports estimated catastrophe losses of $435 million after taxes in August.
Why You Should Add Brown & Brown (BRO) Stock to Your Portfolio
by Zacks Equity Research
Solid new businesses, premium-rate increases across the majority of business lines, expansion initiatives, strategic acquisitions and a strong financial position continue to drive Brown & Brown (BRO).
CME Group (CME) to Introduce Cobalt Hydroxide Futures on Oct 23
by Zacks Equity Research
CME Group (CME) is set to address the need for a hedging instrument in the battery space with the launch of Cobalt Hydroxide futures.
Wall Street Analysts Predict a 25.01% Upside in Trupanion (TRUP): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 25% in Trupanion (TRUP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
CME Group (CME) to Introduce Options on Micro Gold Futures
by Zacks Equity Research
CME Group (CME) introduces options on Micro Gold Futures to cater to the growing demand for gold products.
AON Stock Jumps 14% in a Year: More Growth on the Horizon?
by Zacks Equity Research
AON is poised for long-term growth on the back of Strategy and Technology Group performance, talent investments, and improving operations in multiple regions.
Manulife (MFC) Enhances Product Suite With New Medicine Program
by Zacks Equity Research
Manulife (MFC) launches Personalized Medicine Program for Enhanced Health Care members in Canada.
Here's Why You Should Add Primerica (PRI) to Your Portfolio
by Zacks Equity Research
Higher premiums in term life insurance, increasing sales force and improving senior health business should poise Primerica (PRI) well for growth.